Tuesday, 31 July 2012

project topics in chemistry and pharmaceutics

Method Development of Capecitabine HCl by HPLC

Method Development of  Resveratrol by HPLC

Method Development of Ropinarole by HPLC

Method Development of  Gefitinib by HPLC

Method Development of  Dorzolamide by HPLC

Estimation of Esomeprazole Magnesium in Pharma Dosage Forms  by HPLC

Estimation of  Fluconazole in Pharma Dosage Forms  by HPLC

Estimation of  Loratadine in Pharma Dosage Forms  by HPLC

Estimation of  Quetiapine Femarate in Pharma Dosage Forms  by HPLC

Estimation of  Gabapentin in Pharma Dosage Forms  by HPLC

UV Visible Method For Estimation Of Rebaprazole Sodium in the Dosage Forms

UV Visible Method For Estimation Of  Pentoprazole Sodium in the Dosage Forms

UV Visible Method For Estimation Of  Tadalafil in the Dosage Forms

UV Visible Method For Estimation Of  Sertraline HCl in the Dosage Forms

UV Visible Method For Estimation Of  Irbesatran HCl in the Dosage Forms

Simultaneous Estimation of Omeprazole and Domperidone by HPLC

Simultaneous Estimation of Metformine HCl and Pioglitazole by HPLC

Simultaneous Estimation of Rabeprazole and Domperidone by HPLC

Simultaneous Estimation of Nebivolol and Hydrochlorothiazide by HPLC

Simultaneous Estimation of Cefixime and Ornidazole by HPLC

RP- HPLC Method Development of Ofloxacin and Ornidazole by HPLC

RP- HPLC Method Development of Montelukaust Sodium and Cetrizine by HPLC

RP- HPLC Method Development of Amlodipine and Atorvostatine by HPLC

RP- HPLC Method Development of Lamividine and Zodovidine by HPLC

RP- HPLC Method Development of Losartan Potassium and Rosuvastatine by HPLC

Dissolution Studies of  Metformine Sustain Release Pellets

Dissolution Studies of Diclofenac Sodium Sustain Release Pellets

Dissolution Studies of Indomethacin Sustain Release Pellets

Dissolution Studies of Cefixime Immediate Release Pellets

Dissolution Studies of  Pentoprazole Sodium Enteric Coated Release Pellets

No comments:

Post a Comment